Premier Inc. Grants Technology Breakthrough Designation to Delphinus

Delphinus Medical Technologies has been awarded a national group purchasing agreement and Technology Breakthrough designation for its SoftVue Breast Ultrasound Tomography (UST) from Premier Inc.

As a result of the designation, Delphinus is now listed as a top supplier for Premier’s members. 
 
Premier offers Technology Breakthrough designations to innovations that offer major advantages in patient safety, clinical outcomes, and operational efficiencies. Over several months, Premier reviews each product submitted for consideration to determine if it uses innovative technology and provides significant benefits for healthcare organizations and stakeholders.
 
“By receiving the Technology Breakthrough agreement from Premier, SoftVue is recognized as a product that represents a major advancement in driving high-quality, cost-effective care, and we couldn’t agree more,” Delphinus Medical Technologies CEO Scott White said. “We look forward to continuing to expand our network of customers, through Premier’s alliance, that use our breast imaging technology as an effective supplemental screening method, in combination with mammogram, for women with dense breasts.”
 
SoftVue is approved by the U.S. Food and Drug Administration for same-day screening as mammography, and when paired with mammography, shows superiority in cancer detection for women with dense breasts compared to mammography alone. SoftVue has been shown to identify up to 25% more cancers while also decreasing unnecessary call-backs and short term follow-up in women with dense breasts. Delphinus designed the system to address the fact that breast cancer screening with mammography alone reduces mortality by only 13% in women with dense breasts. SoftVue can be performed during the same visit as the women’s mammogram, saving patients time and improving the diagnostic clinical workflow for breast centers.
 
Premier is a healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. 
 
Headquartered in Novi, Mich., Delphinus Medical Technologies is a medical imaging company that developed SoftVue, featuring the first circular array transducer technology. The patented technology is a 3D whole-breast ultrasound tomography system that delivers no radiation, requires no compression, and images the entire breast with a single scan.